Literature DB >> 25129277

The Anp genetic variant Rs5068 and circulating levels of natriuretic peptides in patients with chronic heart failure.

Valentina Cannone1, Simona Barlera2, Silvana Pileggi2, Serge Masson2, Maria Grazia Franzosi2, Roberto Latini2, Cesare Scardulla3, Francesco Clemenza3, Aldo P Maggioni4, Gian Luigi Nicolosi5, Luigi Tavazzi6, John C Burnett7.   

Abstract

Entities:  

Keywords:  Atrial natriuretic peptide; B-type natriuretic peptide; Genetic variant; Heart failure; Natriuretic peptides; rs5068

Mesh：

Substances：

Year:  2014        PMID： 25129277      PMCID： PMC4513354          DOI： 10.1016/j.ijcard.2014.07.200

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  10 in total

1.  Heart failure: a state of brain natriuretic peptide deficiency or resistance or both!

Authors:  Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2007-02-26       Impact factor: 24.094

2.  Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure.

Authors:  Adam M Hawkridge; Denise M Heublein; H Robert Bergen; Alessandro Cataliotti; John C Burnett; David C Muddiman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-17       Impact factor: 11.205

3.  A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.

Authors:  Valentina Cannone; Guido Boerrigter; Alessandro Cataliotti; Lisa C Costello-Boerrigter; Timothy M Olson; Paul M McKie; Denise M Heublein; Brian D Lahr; Kent R Bailey; Maurizio Averna; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2011-08-02       Impact factor: 24.094

Review 4.  An unsuspected metabolic role for atrial natriuretic peptides: the control of lipolysis, lipid mobilization, and systemic nonesterified fatty acids levels in humans.

Authors:  Max Lafontan; Cédric Moro; Coralie Sengenes; Jean Galitzky; François Crampes; Michel Berlan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08-25       Impact factor: 8.311

Review 5.  The endocrine function of the heart.

Authors:  Monica Forero McGrath; Mercedes L Kuroski de Bold; Adolfo J de Bold
Journal:  Trends Endocrinol Metab       Date:  2005-11-02       Impact factor: 12.015

6.  Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.

Authors:  Christopher Newton-Cheh; Martin G Larson; Ramachandran S Vasan; Daniel Levy; Kenneth D Bloch; Aarti Surti; Candace Guiducci; Sekar Kathiresan; Emelia J Benjamin; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Stefan Blankenberg; Frank Kee; Peter Nilsson; Xiaoyan Yin; Leena Peltonen; Erkki Vartiainen; Veikko Salomaa; Joel N Hirschhorn; Olle Melander; Thomas J Wang
Journal:  Nat Genet       Date:  2009-02-15       Impact factor: 38.330

7.  Atrial natriuretic peptide is negatively regulated by microRNA-425.

Authors:  Pankaj Arora; Connie Wu; Abigail May Khan; Donald B Bloch; Brandi N Davis-Dusenbery; Anahita Ghorbani; Ester Spagnolli; Andrew Martinez; Allicia Ryan; Laurel T Tainsh; Samuel Kim; Jian Rong; Tianxiao Huan; Jane E Freedman; Daniel Levy; Karen K Miller; Akiko Hata; Federica Del Monte; Sara Vandenwijngaert; Melissa Swinnen; Stefan Janssens; Tara M Holmes; Emmanuel S Buys; Kenneth D Bloch; Christopher Newton-Cheh; Thomas J Wang
Journal:  J Clin Invest       Date:  2013-07-15       Impact factor: 14.808

8.  Cachexia: a new definition.

Authors:  William J Evans; John E Morley; Josep Argilés; Connie Bales; Vickie Baracos; Denis Guttridge; Aminah Jatoi; Kamyar Kalantar-Zadeh; Herbert Lochs; Giovanni Mantovani; Daniel Marks; William E Mitch; Maurizio Muscaritoli; Armine Najand; Piotr Ponikowski; Filippo Rossi Fanelli; Morrie Schambelan; Annemie Schols; Michael Schuster; David Thomas; Robert Wolfe; Stefan D Anker
Journal:  Clin Nutr       Date:  2008-08-21       Impact factor: 7.324

9.  Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Authors:  Luigi Tavazzi; Aldo P Maggioni; Roberto Marchioli; Simona Barlera; Maria Grazia Franzosi; Roberto Latini; Donata Lucci; Gian Luigi Nicolosi; Maurizio Porcu; Gianni Tognoni
Journal:  Lancet       Date:  2008-08-29       Impact factor: 79.321

10.  The atrial natriuretic peptide genetic variant rs5068 is associated with a favorable cardiometabolic phenotype in a Mediterranean population.

Authors:  Valentina Cannone; Angelo Baldassare Cefalu'; Davide Noto; Christopher G Scott; Kent R Bailey; Giovanni Cavera; Michele Pagano; Michelangelo Sapienza; Maurizio R Averna; John C Burnett
Journal:  Diabetes Care       Date:  2013-05-01       Impact factor: 19.112
  10 in total
  1 in total

1.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.